FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Buckley

Research Profile

Disorders

Chemicals & Drugs

Activities & Behaviors

Schizophrenic Psychology

Concepts & Ideas

Anatomy

Geographic Areas

United States

Living Beings

Psychiatry

Objects

Co-author Network

Publications

TOP 3
Brian J Miller; Jennifer L Waller; Chelsea M Bodenheimer; Nick H Culpepper; Krystle L Graham; Peter F Buckley
A prevalence study of urinary tract infections in acute relapse of schizophrenia.
Anthony O Ahmed; Peter F Buckley; Mona Hanna
Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important?
Peter F Buckley
Early diagnosis and intervention in schizophrenia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Buckley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Brian J Miller; Jennifer L Waller; Chelsea M Bodenheimer; Nick H Culpepper; Krystle L Graham; Peter F Buckley
A prevalence study of urinary tract infections in acute relapse of schizophrenia.
The Journal of clinical psychiatry 2013;74(3):271-7.
2013: Anthony O Ahmed; Peter F Buckley; Mona Hanna
Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important?
Current psychiatry reports 2013;15(3):345.
2012: Peter F Buckley
Early diagnosis and intervention in schizophrenia.
The Psychiatric clinics of North America 2012;35(3):xiii.
2012: Anthony O Ahmed; Denis Birgenheir; Peter F Buckley; Nancy J Doane; Paul A Mabe; Nada M Goodrum
Peers and peer-led interventions for people with schizophrenia.
The Psychiatric clinics of North America 2012;35(3):699-715.
2012: Anilkumar Pillai; Peter F Buckley
Reliable biomarkers and predictors of schizophrenia and its treatment.
The Psychiatric clinics of North America 2012;35(3):645-59.
2012: Peter F Buckley
Welcome to the April '12 issue of Clinical Schizophrenia and Related Psychoses (CS). Introduction.
Clinical schizophrenia & related psychoses 2012;6(1):4.
2012: Anthony Olufemi Ahmed; Peter F Buckley; Bradley Andrew Green; Megan Elizabeth McFarland
Taxometric analyses of paranoid and schizoid personality disorders.
Psychiatry research 2012;196(1):123-32.
2012: Anilkumar Pillai; Nunzio Pomara; Leslie A Saint-Louis; Antero S Sarreal; Henrik Zetterberg; Stephen D Ginsberg; Raymundo T Hernando; Pankaj D Mehta; Jay Nierenberg; Kaj Blennow; Davide Bruno; Peter F Buckley
Plasma BDNF levels vary in relation to body weight in females.
PloS one 2012;7(7):e39358.
2012: Peter F Buckley
Clinical Schizophrenia & Related Psychoses' (CS) fifth year of publication.
Clinical schizophrenia & related psychoses 2012;5(4):172.
2012: A O Ahmed; Peter F Buckley; P A Mabe
Latent structure of psychotic experiences in the general population.
Acta psychiatrica Scandinavica 2012;125(1):54-65.
2011: Peter F Buckley
Bromization: the truths we know about the psychopharmacology of schizophrenia.
The Journal of nervous and mental disease 2011;199(10):736-7.
2011: Peter F Buckley; Leslie Citrome; Elena Carmen Nichita; Michael Vitacco
Psychopharmacology of aggression in schizophrenia.
Schizophrenia bulletin 2011;37(5):930-6.
2011: Michael T Compton; Raymond C K Chan; Elaine F Walker; Peter F Buckley
Minor physical anomalies: potentially informative vestiges of fetal developmental disruptions in schizophrenia.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2011;29(3):245-50.
2011: Kelin M Ogburn; Erick Messias; Peter F Buckley
New-age patient communications through social networks.
General hospital psychiatry 2011;33(2):200.e1-3.
2011: Peter F Buckley; R Kevin Grigsby
A propitious moment in the midst of crisis: a case study of organizational change in an academic department.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2011;35(2):143-8.
2011: Peter F Buckley; William F Rayburn
Turnover of first-time Chairs in departments of psychiatry.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2011;35(2):126-8.
2011: Samuel J Keith; Peter F Buckley
Leadership experiences and characteristics of chairs of academic departments of psychiatry.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2011;35(2):118-21.
2011: Peter F Buckley; Anilkumar R Pillai; Kristy R Howell
Brain-derived neurotrophic factor: findings in schizophrenia.
Current opinion in psychiatry 2011;24(2):122-7.
2011: Scott P Van Sant; Peter F Buckley
Pharmacotherapy for treatment-refractory schizophrenia.
Expert opinion on pharmacotherapy 2011;12(3):411-34.
2011: John M Kane; Steven G Potkin; David G Daniel; Peter F Buckley
A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
The Journal of clinical psychiatry 2011;72(2):194-204.
2011: Peter F Buckley
GHSU: addressing the state's physician shortage.
Journal of the Medical Association of Georgia 2011;100(3):21-2.
2010: Adriana Elena Foster; Del D Miller; Peter F Buckley
Pharmacogenetics and schizophrenia.
Clinics in laboratory medicine 2010;30(4):975-93.
2010: John M Kane; Thomas R E Barnes; Christoph Correll; Gary Sachs; Peter F Buckley; James M Eudicone; Robert D McQuade; Quynh-Van Tran; Andrei Pikalov; Sheila Assunção-Talbott
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.
Journal of psychopharmacology (Oxford, England) 2010;24(7):1019-29.
2010: Peter F Buckley; William F Rayburn
The care and feeding of chairs of departments of psychiatry.
The American journal of psychiatry 2010;167(4):376-8.
2010: Susan Lenderts; Amir Kalali; Peter F Buckley
Generic penetration in the retail atypical antipsychotic market.
Psychiatry (Edgmont (Pa. : Township)) 2010;7(3):9-10.
2010: John A Talbott; Larry R Faulkner; Peter F Buckley
State hospital-university collaborations: a 25-year follow-up.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2010;34(2):125-7.
2009: Ilya A Lipkovich; Walter Deberdt; John G Csernansky; Peter F Buckley; Joseph Peuskens; Sara Kollack-Walker; Matthew Rotelli; John P Houston
Defining "good" and "poor" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approach.
Psychiatry research 2009;170(2-3):161-7.
2009: Scott A Peebles; Paul A Mabe; Gareth Fenley; Peter F Buckley; Travis O Bruce; Meera Narasimhan; Leslie Frinks; Eric Williams
Immersing practitioners in the recovery model: an educational program evaluation.
Community mental health journal 2009;45(4):239-45.
2009: Jean-Pierre Lindenmayer; Hong Liu-Seifert; Pandurang M Kulkarni; Bruce J Kinon; Virginia L Stauffer; Sara E Edwards; Lei Chen; David H Adams; Haya Ascher-Svanum; Peter F Buckley; Leslie Citrome; Jan Volavka
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.
The Journal of clinical psychiatry 2009;70(7):990-6.
2009: Jayendra K Patel; Peter F Buckley; Sandra Woolson; Robert M Hamer; Joseph P McEvoy; Diana O Perkins; Jeffrey A Lieberman
Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.
Schizophrenia research 2009;111(1-3):9-16.
2009: Elisa Cascade; Amir Kalali; Peter F Buckley
Treatment of schizoaffective disorder.
Psychiatry (Edgmont (Pa. : Township)) 2009;6(3):15-7.
2009: Peter F Buckley; Brian J Miller; Douglas S Lehrer; David J Castle
Psychiatric comorbidities and schizophrenia.
Schizophrenia bulletin 2009;35(2):383-402.
2009: Yan Chen; Jeff J Guo; Michael Steinbuch; Peter F Buckley; Nick C Patel
Risk of neuroleptic malignant syndrome in patients with bipolar disorder: a retrospective, population-based case-control study.
International journal of psychiatry in medicine 2009;39(4):439-50.
2008: Bruce J Kinon; Jan Volavka; Virginia Stauffer; Sara E Edwards; Hong Liu-Seifert; Lei Chen; David H Adams; Jean-Pierre Lindenmayer; Joseph P McEvoy; Peter F Buckley; Jeffrey A Lieberman; Herbert Y Meltzer; Daniel R. Wilson; Leslie Citrome
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.
Journal of clinical psychopharmacology 2008;28(4):392-400.
2008: Elisa F Cascade; Amir Kalali; Peter F Buckley
Current Management of Schizophrenia: Antipsychotic Monotherapy versus Combination Therapy.
Psychiatry (Edgmont (Pa. : Township)) 2008;5(5):28-30.
2008: Peter F Buckley
Treating movement disorders and akathisia as side effects of antipsychotic pharmacotherapy.
The Journal of clinical psychiatry 2008;69(5):e14.
2008: Peter F Buckley; Vishal Madaan
Leadership and professional workforce development.
The Psychiatric clinics of North America 2008;31(1):105-22.
2008: Peter F Buckley
Update on the treatment and management of schizophrenia and bipolar disorder.
CNS spectrums 2008;13(2 Suppl 1):1-10; quiz 11-2.
2008: Peter F Buckley
Factors that influence treatment success in schizophrenia.
The Journal of clinical psychiatry 2008;69 Suppl 3():4-10.
2008: Peter F Buckley; Christoph Correll
Strategies for dosing and switching antipsychotics for optimal clinical management.
The Journal of clinical psychiatry 2008;69 Suppl 1():4-17.
2007: Adriana Elena Foster; Zixuan Wang; Manzoor Usman; Edna Stirewalt; Peter F Buckley
Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians.
Neuropsychiatric disease and treatment 2007;3(6):965-73.
2007: Peter F Buckley; Daniel Bahmiller; Courtney Amanda Kenna; Stewart Shevitz; Ike Powell; Larry Fricks
Resident education and perceptions of recovery in serious mental illness: observations and commentary.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2007;31(6):435-8.
2007: Troy A Moore; Robert W Buchanan; Peter F Buckley; John A Chiles; Robert R Conley; M Lynn Crismon; Susan M Essock; Molly Finnerty; Stephen R Marder; Joseph P McEvoy; Delbert Robinson; Nina R Schooler; Steven P Shon; Thomas Stroup; Del D Miller; Alexander Miller
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
The Journal of clinical psychiatry 2007;68(11):1751-62.
2007: Peter F Buckley
Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
CNS spectrums 2007;12(10 Suppl 18):7-10.
2007: Peter F Buckley; Christoph Correll; Alexander Miller
First-episode psychosis: a window of opportunity for best practices.
CNS spectrums 2007;12(9 Suppl 15):1-12; discussion 13-4; quiz 15-6.
2007: Scott A Peebles; Paul A Mabe; Larry Davidson; Larry Fricks; Peter F Buckley; Gareth Fenley
Recovery and systems transformation for schizophrenia.
The Psychiatric clinics of North America 2007;30(3):567-83.
2007: Peter Weiden; Peter F Buckley; Michael Grody
Understanding and treating "first-episode" schizophrenia.
The Psychiatric clinics of North America 2007;30(3):481-510.
2007: Adriana Elena Foster; Del D Miller; Peter F Buckley
Pharmacogenetics and schizophrenia.
The Psychiatric clinics of North America 2007;30(3):417-35.
2007: Adriana Elena Foster; Manzoor Usman; Edna Stirewalt; Peter F Buckley
Schizophrenia: from brain morphology to psychopathology.
Current psychiatry reports 2007;9(4):337-42.
2007: Peter F Buckley; Sahebarao Mahadik; Anilkumar R Pillai; Alvin V Terry
Neurotrophins and schizophrenia.
Schizophrenia research 2007;94(1-3):1-11.
2007: Peter F Buckley; Philip D Harvey; Christopher R Bowie; Antony Loebel
The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone.
Schizophrenia research 2007;94(1-3):99-106.
2007: Ilya Lipkovich; Walter Deberdt; J G Csernansky; Peter F Buckley; J Peuskens; Sara Kollack-Walker; Y Zhang; Hong Liu-Seifert; John P Houston
Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy.
Journal of psychiatric research 2007;41(3-4):305-10.
2007: Elena Carmen Nichita; Peter F Buckley
Informed consent and competency: doctor's dilemma on the consultation liaison service.
Psychiatry (Edgmont (Pa. : Township)) 2007;4(3):53-5.
2007: Peter F Buckley; Lucille F Meinsler
The history of the American Association of Chairs of Departments of Psychiatry.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2007;31(2):97-8.
2007: Peter F Buckley; Anilkumar R Pillai; Denise Evans; Edna Stirewalt; Sahebarao Mahadik
Brain derived neurotropic factor in first-episode psychosis.
Schizophrenia research 2007;91(1-3):1-5.
2007: Peter F Buckley; S M Stahl
Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?
Acta psychiatrica Scandinavica 2007;115(2):93-100.
2007: Peter Weiden; Peter F Buckley
Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.
The Journal of clinical psychiatry 2007;68 Suppl 6():14-23.
2007: Peter F Buckley
Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents.
The Journal of clinical psychiatry 2007;68 Suppl 6():5-9.
2007: Peter F Buckley
Introduction: the art and science of switching antipsychotic medications.
The Journal of clinical psychiatry 2007;68 Suppl 6():4.
2007: Peter F Buckley; Björn Paulsson; Martin Brecher
Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
Journal of affective disorders 2007;100 Suppl 1():S33-43.
2007: Peter Weiden; Alexander Miller; Tim J Lambert; Peter F Buckley
The art and science of switching antipsychotic medications, part 2.
The Journal of clinical psychiatry 2007;68(1):e02.
2007: Peter F Buckley; Donna A Wirshing; Prameet Bhushan; Joseph M Pierre; Seth A. Resnick; William C Wirshing
Lack of insight in schizophrenia: impact on treatment adherence.
CNS drugs 2007;21(2):129-41.
2007: S M Stahl; Peter F Buckley
Negative symptoms of schizophrenia: a problem that will not go away.
Acta psychiatrica Scandinavica 2007;115(1):4-11.
2006: Peter Weiden; Allan H Young; Peter F Buckley
The art and science of switching of antipsychotic medications, part 1.
The Journal of clinical psychiatry 2006;67(11):e15.
2006: Peter F Buckley; Denise Evans
First-episode schizophrenia. A window of opportunity for optimizing care and outcomes.
Postgraduate medicine 2006;Spec No():5-19.
2006: Peter F Buckley; E Sherwood Brown
Prevalence and consequences of dual diagnosis.
The Journal of clinical psychiatry 2006;67(7):e01.
2006: Peter F Buckley
Reflections on leadership as chair of a department of psychiatry.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2006;30(4):309-14.
2006: Peter F Buckley
Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
The Journal of clinical psychiatry 2006;67 Suppl 7():5-9.
2006: Douglas A Smith; Peter F Buckley
Pharmacotherapy of delusional disorders in the context of offending and the potential for compulsory treatment.
Behavioral sciences & the law 2006;24(3):351-67.
2005: Peter F Buckley; Del D Miller; Beth Singer; John Arena; Edna Stirewalt
Clinicians' recognition of the metabolic adverse effects of antipsychotic medications.
Schizophrenia research 2005;79(2-3):281-8.
2005: Peter F Buckley
Olanzapine: a critical review of recent literature.
Expert opinion on pharmacotherapy 2005;6(12):2077-89.
2005: Peter F Buckley
Dosing equivalency of second-generation antipsychotic medications.
Journal of clinical psychopharmacology 2005;25(5):501-2; discussion 502-4.
2005: Peter F Buckley
Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications.
Neuropsychiatric disease and treatment 2005;1(3):193-204.
2005: Casey S Gilmore; Brett A Clementz; Peter F Buckley
Stimulus sequence affects schizophrenia-normal differences in event processing during an auditory oddball task.
Brain research. Cognitive brain research 2005;24(2):215-27.
2005: Peter F Buckley; Nitin Sudhakar Shendarkar
Treatment-refractory schizophrenia.
Current opinion in psychiatry 2005;18(2):165-73.
2005: Peter F Buckley; David Dean; Fred L Bookstein; Seungho Han; Michael Yerukhimovich; Kyoung-June Min; Beth Singer
A three-dimensional morphometric study of craniofacial shape in schizophrenia.
The American journal of psychiatry 2005;162(3):606-8.
2005: Del D Miller; Vicki E Ringold; Timothy L Holman; Peter F Buckley; Stephan Arndt
Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;133B(1):97-100.
2005: David L Ginsberg; Nina R Schooler; Peter F Buckley; Philip D Harvey; Peter Weiden
Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functioning.
CNS spectrums 2005;10(2):1-13; discussion 14-15.
2005: Peter F Buckley
Second-generation antipsychotic medications in the treatment of mood disorders: focus on aripiprazole.
Drugs of today (Barcelona, Spain : 1998) 2005;41(1):5-11.
2004: Casey S Gilmore; Brett A Clementz; Peter F Buckley
Rate of stimulation affects schizophrenia-normal differences on the N1 auditory-evoked potential.
Neuroreport 2004;15(18):2713-7.
2004: Peter F Buckley
Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Current medical research and opinion 2004;20(9):1357-63.
2004: Peter F Buckley
Effective dosing and dose equivalency of second-generation antipsychotic medications.
CNS spectrums 2004;9(9 Suppl 9):24-31.
2004: Peter F Buckley; Debra R Hrouda; Lee Friedman; Stephen G Noffsinger; Phillip J Resnick; Kelly Camlin-Shingler
Insight and its relationship to violent behavior in patients with schizophrenia.
The American journal of psychiatry 2004;161(9):1712-4.
2004: Alexander Miller; Catherine S Hall; Robert W Buchanan; Peter F Buckley; John A Chiles; Robert R Conley; M Lynn Crismon; Larry Ereshefsky; Susan M Essock; Molly Finnerty; Stephen R Marder; Del D Miller; Joseph P McEvoy; A John Rush; Sy A Saeed; Nina R Schooler; Steven P Shon; Scott Stroup; Bernardo Tarin-Godoy
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.
The Journal of clinical psychiatry 2004;65(4):500-8.
2004: Peter F Buckley
Maintenance treatment for schizophrenia with quetiapine.
Human psychopharmacology 2004;19(2):121-4.
2004: Peter F Buckley; Jeffrey M Goldstein; Robin A Emsley
Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia.
Schizophrenia research 2004;66(2-3):143-50.
2004: C Simon Sebastian; William Glazer; Peter F Buckley
Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
Current medicinal chemistry 2004;11(3):329-42.
2004: Bruce J Kinon; Jonna Ahl; Virginia L Stauffer; Angela L Hill; Peter F Buckley
Dose response and atypical antipsychotics in schizophrenia.
CNS drugs 2004;18(9):597-616.
2003: Denise R Evans; Vinay Parikh; Mohammad M Khan; C Coussons; Peter F Buckley; Sahebarao Mahadik
Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment.
Prostaglandins, leukotrienes, and essential fatty acids 2003;69(6):393-9.
2003: Robin A Emsley; Peter F Buckley; A Martin Jones; Michael R Greenwood
Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia.
Journal of psychopharmacology (Oxford, England) 2003;17(2):210-5.
2003: Muhammad N Momen; C Simon Sebastian; Peter F Buckley
Paradoxical reaction to fluoxetine.
Psychosomatics 2003;44(3):259-60.
2003: Peter F Buckley; Stephen G Noffsinger; Douglas A Smith; Debra R Hrouda; James L Knoll
Treatment of the psychotic patient who is violent.
The Psychiatric clinics of North America 2003;26(1):231-72.
2003: Peter F Buckley
Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic.
Drugs of today (Barcelona, Spain : 1998) 2003;39(2):145-51.
2002: Martha Sajatovic; Debra S Rosch; Harry J Sivec; Dilara Sultana; Douglas A Smith; Samer Alamir; Peter F Buckley; C Raymond Bingham
Insight into illness and attitudes toward medications among inpatients with schizophrenia.
Psychiatric services (Washington, D.C.) 2002;53(10):1319-21.
2002: Martha Sajatovic; Dilara Sultana; C Raymond Bingham; Peter F Buckley; Karl Donenwirth
Gender related differences in clinical characteristics and hospital based resource utilization among older adults with schizophrenia.
International journal of geriatric psychiatry 2002;17(6):542-8.
2002: Peter F Buckley; Lee Friedman; John A Jesberger; S Charles Schulz; george jaskiw
Head size and schizophrenia.
Schizophrenia research 2002;55(1-2):99-104.
2001: Peter F Buckley
Broad therapeutic uses of atypical antipsychotic medications.
Biological psychiatry 2001;50(11):912-24.
2001: Peter F Buckley; L D Wiggins; C Simon Sebastian; B Singer
Treatment-refractory schizophrenia.
Current psychiatry reports 2001;3(5):393-400.
2001: Peter F Buckley; M Dayem; G Parker; L Weisser
Schizophrenia today: what do we know-and how sure are we?
Journal of psychiatric practice 2001;7(4):244-6.
2001: Peter F Buckley; L Friedman; A C Krowinski; Y Eaton; M Tronetti; D D Miller
Clinical and biochemical correlates of "high-dose" clozapine therapy for treatment-refractory schizophrenia.
Schizophrenia research 2001;49(1-2):225-7.
2001: Peter F Buckley; D D Miller; B Singer; Karl Donenwirth
The evolving clinical profile of atypical antipsychotic medications.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2001;46(3):285.
2001: Peter F Buckley; Alexander Miller; J Olsen; D Garver; D D Miller; J Csernansky
When symptoms persist: clozapine augmentation strategies.
Schizophrenia bulletin 2001;27(4):615-28.
2001: Peter F Buckley; S Hasan; L Friedman; C Cerny
Insight and schizophrenia.
Comprehensive psychiatry 2001;42(1):39-41.
2001: J G Katz; G Gintoli; Peter F Buckley
BART's place for children and teenagers of parents with serious mental illness.
Psychiatric services (Washington, D.C.) 2001;52(1):107.
2000: Martha Sajatovic; Karl Donenwirth; Dilara Sultana; Peter F Buckley
Admissions, length of stay, and medication use among women in an acute care state psychiatric facility.
Psychiatric services (Washington, D.C.) 2000;51(10):1278-81.
2000: Peter F Buckley
Ziprasidone: pharmacology, clinical progress and therapeutic promise.
Drugs of today (Barcelona, Spain : 1998) 2000;36(8):583-9.
2000: Peter F Buckley
Comprehensive disease management for schizophrenia.
Drugs of today (Barcelona, Spain : 1998) 2000;36(5):267-80.
2000: Lee Friedman; I R Wiechers; C A Cerny; S Charles Schulz; Peter F Buckley
If patients with schizophrenia have small brains, why don't they have small heads?
Schizophrenia research 2000;42(1):1-6.
2000: Peter F Buckley; L Friedman
Magnetic resonance spectroscopy. Bridging the neurochemistry and neuroanatomy of schizophrenia.
The British journal of psychiatry : the journal of mental science 2000;176():203-5.
2000: Peter F Buckley; T Robben
A content analysis of state hospital policies on sex between inpatients.
Psychiatric services (Washington, D.C.) 2000;51(2):243-5.
2000: Peter F Buckley; Robert W Buchanan; Carol A Tamminga; S C Schulz
Schizophrenia research: a progress report, summarizing proceedings of the 1999 International Congress on Schizophrenia Research.
Schizophrenia bulletin 2000;26(2):411-9.
1999: Peter F Buckley; I R Wiechers
Sexual behavior of psychiatric inpatients: hospital responses and policy formulation.
Community mental health journal 1999;35(6):531-6.
1999: Peter F Buckley; Alexander Miller; John A Chiles; Martha Sajatovic
Implementing effectiveness research and improving care for schizophrenia in real-world settings.
The American journal of managed care 1999;5 Spec No():SP47-56.
1999: Peter F Buckley
The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
The Journal of clinical psychiatry 1999;60 Suppl 10():52-60.
1999: Debra A Pinals; Peter F Buckley
Novel antipsychotic agents and their implications for forensic psychiatry.
The journal of the American Academy of Psychiatry and the Law 1999;27(1):7-22.
1999: Peter F Buckley
New antipsychotic agents: emerging clinical profiles.
The Journal of clinical psychiatry 1999;60 Suppl 1():12-7; discussion 28-30.
1999: Peter F Buckley; D Dean; F L Bookstein; Lee Friedman; D Kwon; JONATHAN LEWIN; J Kamath; Christine Lys
Three-dimensional magnetic resonance-based morphometrics and ventricular dysmorphology in schizophrenia.
Biological psychiatry 1999;45(1):62-7.
1998: Peter F Buckley; S Hasan
Atypical neuroleptic malignant syndrome and atypical antipsychotics.
The American journal of psychiatry 1998;155(11):1633.
1998: Peter F Buckley
Novel antipsychotics and patient care in state hospitals.
The Annals of pharmacotherapy 1998;32(9):906-14.
1998: S Hasan; Peter F Buckley
Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
The American journal of psychiatry 1998;155(8):1113-6.
1998: John L Waddington; Peter F Buckley; Paul J Scully; A Lane; Eadbhard O'Callaghan; C Larkin
Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics?
Journal of psychiatric research 1998;32(3-4):179-89.
1998: Peter F Buckley
Treatment of schizophrenia: let's talk dollars and sense.
The American journal of managed care 1998;4(3):369-83.
1998: Peter F Buckley
Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia.
Journal of substance abuse treatment 1998;15(2):113-6.
1998: Peter F Buckley
Structural brain imaging in schizophrenia.
The Psychiatric clinics of North America 1998;21(1):77-92.
1998: Peter F Buckley
The clinical stigmata of aberrant neurodevelopment in schizophrenia.
The Journal of nervous and mental disease 1998;186(2):79-86.
1998: Robert W Buchanan; Peter F Buckley; Carol A Tamminga; S C Schulz
Schizophrenia research: a biennium of progress. Proceedings from the Sixth International Congress on Schizophrenia Research. Colorado Springs, CO, April 12-16, 1997.
Schizophrenia bulletin 1998;24(4):501-18.
1998: Peter F Buckley
Substance abuse in schizophrenia: a review.
The Journal of clinical psychiatry 1998;59 Suppl 3():26-30.
1997: Peter F Buckley
New dimensions in the pharmacologic treatment of schizophrenia and related psychoses.
Journal of clinical pharmacology 1997;37(5):363-78.
1997: S Imbornoni; Karl Donenwirth; B Orr; T Hagesfeld; G Gintoli; Peter F Buckley
Objective measurement of psychiatric symptoms: a quality improvement process for inpatient care.
The Joint Commission journal on quality improvement 1997;23(4):183-95.
1997: Peter F Buckley; Lee Friedman; D Wu; S Lai; Herbert Y Meltzer; E Mark Haacke; D Miller; JONATHAN LEWIN
Functional magnetic resonance imaging in schizophrenia: initial methodology and evaluation of the motor cortex.
Psychiatry research 1997;74(1):13-23.
1997: Peter F Buckley; J L Hyde
State hospitals' responses to the sexual behavior of psychiatric inpatients.
Psychiatric services (Washington, D.C.) 1997;48(3):398-9.
1997: Peter F Buckley; Z Y Ibrahim; B Singer; B Orr; Karl Donenwirth; P S Brar
Aggression and schizophrenia: efficacy of risperidone.
The journal of the American Academy of Psychiatry and the Law 1997;25(2):173-81.
1996: Peter F Buckley
Treatment of schizophrenia: advances during the decade of the brain.
British journal of hospital medicine 1996;56(11):574-80.
1996: Peter F Buckley; S Charles Schulz
Clozapine and risperidone: refining and extending their use.
Harvard review of psychiatry 1996;4(4):184-99.
1996: Peter F Buckley; J L Hyde; D Winterick
Re: AIDS knowledge and sexual behaviour in patients with schizophrenia.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1996;41(9):603.
1996: JONATHAN LEWIN; Lee Friedman; D Wu; D A Miller; Lee A Thompson; S K Klein; A L Wise; P Hedera; Peter F Buckley; Herbert Y Meltzer; Robert P Friedland; Jeffrey L Duerk
Cortical localization of human sustained attention: detection with functional MR using a visual vigilance paradigm.
Journal of computer assisted tomography 1996;20(5):695-701.
1996: H Elkis; Lee Friedman; Peter F Buckley; H S Lee; Christine Lys; B Kaufman; Herbert Y Meltzer
Increased prefrontal sulcal prominence in relatively young patients with unipolar major depression.
Psychiatry research 1996;67(2):123-34.
1996: Peter F Buckley; Robert W Buchanan; S Charles Schulz; Carol A Tamminga
Catching up on schizophrenia. The Fifth International Congress on Schizophrenia Research, Warm Springs, Va, April 8-12, 1995.
Archives of general psychiatry 1996;53(5):456-62.
1996: Peter F Buckley
Novel antipsychotics and neuroleptic malignant syndrome.
Psychiatric services (Washington, D.C.) 1996;47(4):431.
1996: Peter F Buckley; Christine Lys
Psychotherapy and schizophrenia.
The Journal of psychotherapy practice and research 1996;5(3):185-201.
1996: Peter F Buckley; G Gardner; S Lee; F Torigoe
Role of serotonin in forensic psychiatry.
The Bulletin of the American Academy of Psychiatry and the Law 1996;24(3):419-22.
1995: Eadbhard O'Callaghan; Peter F Buckley; C Madigan; O Redmond; J P Stack; Anthony Kinsella; Conall Larkin; JT Ennis; John L Waddington
The relationship of minor physical anomalies and other putative indices of developmental disturbance in schizophrenia to abnormalities of cerebral structure on magnetic resonance imaging.
Biological psychiatry 1995;38(8):516-24.
1995: A L Mishara; B Orr; Peter F Buckley
Staff perceptions of clozapine and their role in treatment: initial observations.
Journal of psychosocial nursing and mental health services 1995;33(10):44-7.
1995: Peter F Buckley; Eadbhard O'Callaghan; F Mulvany; Conall Larkin; J P Stack; O Redmond; JT Ennis; P Thompson; John L Waddington
Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia.
Psychiatry research 1995;61(2):95-102.
1995: John L Waddington; Eadbhard O'Callaghan; Peter F Buckley; C Madigan; O Redmond; J P Stack; Anthony Kinsella; Conall Larkin; JT Ennis
Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging.
The British journal of psychiatry : the journal of mental science 1995;167(1):41-4.
1995: Peter F Buckley; O Kausch; G Gardner
Clozapine treatment of schizophrenia: implications for forensic psychiatry.
Journal of clinical forensic medicine 1995;2(1):9-16.
1995: Peter F Buckley; Michael Hutchinson
Neuroleptic malignant syndrome.
Journal of neurology, neurosurgery, and psychiatry 1995;58(3):271-3.
1995: Peter F Buckley; J Bartell; Karl Donenwirth; S Lee; F Torigoe; S C Schulz
Violence and schizophrenia: clozapine as a specific antiaggressive agent.
The Bulletin of the American Academy of Psychiatry and the Law 1995;23(4):607-11.
1995: Michael Maes; Herbert Y Meltzer; Peter F Buckley; Eugene Bosmans
Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
European archives of psychiatry and clinical neuroscience 1995;244(6):325-9.
1994: Peter F Buckley; C Moore; H Long; Conall Larkin; P Thompson; F Mulvany; O Redmond; J P Stack; JT Ennis; John L Waddington
1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.
Biological psychiatry 1994;36(12):792-800.
1994: Peter F Buckley; J L Waddington
Magnetic resonance spectroscopy in schizophrenia: a nascent technology for a neurodevelopmental disorder?
Biological psychiatry 1994;36(12):789-91.
1994: Peter F Buckley; A Freyne; N Walshe
The medical-psychiatry unit. A pilot study of conjoint care within an Irish general hospital.
Psychosomatics 1994;35(6):515-9.
1994: Paul Thompson; Peter F Buckley; Herbert Y Meltzer
The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
Journal of clinical psychopharmacology 1994;14(5):344-6.
1994: Peter F Buckley; S C Schulz
Obsessive-compulsive symptoms and clozapine.
The British journal of psychiatry : the journal of mental science 1994;165(3):408.
1994: Peter F Buckley; Paul Thompson; L Way; Herbert Y Meltzer
Substance abuse and clozapine treatment.
The Journal of clinical psychiatry 1994;55 Suppl B():114-6.
1994: Peter F Buckley; Martha Sajatovic; Herbert Y Meltzer
Treatment of delusional disorders with clozapine.
The American journal of psychiatry 1994;151(9):1394-5.
1994: Peter F Buckley; C A O'Donovan
Cerebral asymmetry, planum temporale, and aberrant neurodevelopment in schizophrenia.
Archives of neurology 1994;51(6):540.
1994: Peter F Buckley
Dualism in psychiatry.
Lancet 1994;343(8905):1102.
1994: Peter F Buckley; P Thompson; L Way; Herbert Y Meltzer
Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.
The American journal of psychiatry 1994;151(3):385-9.
1994: E Mark Haacke; A Hopkins; S Lai; Peter F Buckley; L Friedman; Herbert Y Meltzer; P Hedera; Robert P Friedland; S Klein; L Thompson
2D and 3D high resolution gradient echo functional imaging of the brain: venous contributions to signal in motor cortex studies.
NMR in biomedicine 1994;7(1-2):54-62.
1993: Peter F Buckley
Neuroradiological anomalies and schizophrenia.
Journal of neurology, neurosurgery, and psychiatry 1993;56(12):1338.
1993: M Hutchinson; J Stack; Peter F Buckley
Bipolar affective disorder prior to the onset of multiple sclerosis.
Acta neurologica Scandinavica 1993;88(6):388-93.
1993: C Hagger; Peter F Buckley; JT Kenny; Lee Friedman; David Joseph Ubogy; Herbert Y Meltzer
Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.
Biological psychiatry 1993;34(10):702-12.
1993: Shenghan Lai; A L Hopkins; E Mark Haacke; D Li; Bruce A Wasserman; Peter F Buckley; Lee Friedman; Herbert Y Meltzer; P Hedera; Robert P Friedland
Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at 1.5T: preliminary results.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1993;30(3):387-92.
1993: Peter F Buckley
Functional psychoses is the concept disintegrating?
Psychosomatics 1993;34(5):462.
1993: Peter F Buckley; Herbert Y Meltzer
Clozapine and NMS.
The British journal of psychiatry : the journal of mental science 1993;162():566.
1993: Peter F Buckley; M Hutchinson
Psychosis and multiple sclerosis.
The British journal of psychiatry : the journal of mental science 1993;162():422-3.
1993: Peter F Buckley; J P Stack; C Madigan; Eadbhard O'Callaghan; Conall Larkin; O Redmond; JT Ennis; John L Waddington
Magnetic resonance imaging of schizophrenia-like psychoses associated with cerebral trauma: clinicopathological correlates.
The American journal of psychiatry 1993;150(1):146-8.
1992: E O'Callaghan; T Gibson; H A Colohan; Peter F Buckley; D G Walshe; C Larkin; J L Waddington
Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study.
BMJ (Clinical research ed.) 1992;305(6864):1256-9.
1992: A Freyne; Peter F Buckley; C Larkin; N Walsh
Consultation liaison psychiatry within the general hospital: referral pattern and management.
Irish medical journal 1992;85(3):112-4.
1992: Peter F Buckley; E O'Callaghan; C Larkin; J L Waddington
Schizophrenia research: the problem of controls.
Biological psychiatry 1992;32(3):215-7.
1992: Eadbhard O'Callaghan; Peter F Buckley; O Redmond; J Stack; JT Ennis; Conall Larkin; John L Waddington
Abnormalities of cerebral structure in schizophrenia on magnetic resonance imaging: interpretation in relation to the neurodevelopmental hypothesis.
Journal of the Royal Society of Medicine 1992;85(4):227-31.
1992: John L Waddington; Eadbhard O'Callaghan; Peter F Buckley; Conall Larkin; O Redmond; J Stack; JT Ennis
MR imaging and spectroscopy in schizophrenia in relation to the neurodevelopmental hypothesis.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():118A-119A.
1991: John L Waddington; Eadbhard O'Callaghan; Peter F Buckley; Conall Larkin; O Redmond; J Stack; JT Ennis
The age dependencies of MRI abnormalities in schizophrenia suggest early ventricular enlargement but later prominence of cortical atrophy.
Schizophrenia research 1991;5(3):188-9.
1991: E O'Callaghan; T Gibson; H A Colohan; D Walshe; Peter F Buckley; C Larkin; J L Waddington
Season of birth in schizophrenia. Evidence for confinement of an excess of winter births to patients without a family history of mental disorder.
The British journal of psychiatry : the journal of mental science 1991;158():764-9.
1991: Peter F Buckley; A Freyne; A McCarthy; C Larkin
Neuroleptic malignant syndrome--follow-up study.
Irish journal of medical science 1991;160(2):45-7.
1990: Peter F Buckley; C Larkin; E O'Callaghan
Psychosis following use of proprietary antidiarrhoeal medicines.
The British journal of psychiatry : the journal of mental science 1990;157():758-9.
1985: I R Katz; W M Greenberg; Gordon Barr; C Garbarino; Peter F Buckley; D Smith
Screening for cognitive toxicity of anticholinergic drugs.
The Journal of clinical psychiatry 1985;46(8):323-6.